Showing results (1-10 of 30) with videos related to
Sort By:
Pageof 3
Current Cancer Drug Targets|January 10, 2013
Diverse mechanisms of AKT pathway activation in human malignancyMitchell Cheung, Joseph R TestaTranslational Lung Cancer Research|July 18, 2017
<i>BAP1</i>, a tumor suppressor gene driving malignant mesotheliomaMitchell Cheung, Joseph R TestaCancer Research|May 3, 2008
Akt3 and mutant V600E B-Raf cooperate to promote early melanoma developmentMitchell Cheung, Arati Sharma, SubbaRao V Madhunapantula, et al.Current Topics in Microbiology and Immunology|August 27, 2024
Alterations of the AKT Pathway in Sporadic Human Tumors, Inherited Susceptibility to Cancer, and Overgrowth SyndromesCraig W Menges, Dalal Hassan, Mitchell Cheung, et al.The Journal of Biological Chemistry|May 20, 2004
Regulation of B-Raf kinase activity by tuberin and Rheb is mammalian target of rapamycin (mTOR)-independentMagdalena Karbowniczek, Timothy Cash, Mitchell Cheung, et al.Cancer Research|November 4, 2010
Upregulation of DLX5 promotes ovarian cancer cell proliferation by enhancing IRS-2-AKT signalingYinfei Tan, Mitchell Cheung, Jianming Pei, et al.Cancer Research|June 5, 2003
Loss of PTEN promotes tumor development in malignant melanomaJill M Stahl, Mitchell Cheung, Arati Sharma, et al.Cancer Genetics|July 16, 2013
Further evidence for germline BAP1 mutations predisposing to melanoma and malignant mesotheliomaMitchell Cheung, Jacqueline Talarchek, Karen Schindeler, et al.Cancer Letters|September 28, 2015
Germline BAP1 mutation in a family with high incidence of multiple primary cancers and a potential gene-environment interactionMitchell Cheung, Yuwaraj Kadariya, Jacqueline Talarchek, et al.BMC Cancer|February 9, 2010
Onconase responsive genes in human mesothelioma cells: implications for an RNA damaging therapeutic agentDeborah A Altomare, Susanna M Rybak, Jianming Pei, et al.Pageof 3